Healthcare Catch-Up Surge: US Heart and Joint Ops
Americans are catching up on healthcare procedures missed during the COVID-19 pandemic, particularly heart procedures and orthopedic surgeries. The trend ...
- Latest
- Trending
Americans are catching up on healthcare procedures missed during the COVID-19 pandemic, particularly heart procedures and orthopedic surgeries. The trend ...
KalVista Pharmaceuticals achieves key goals in late-stage study for hereditary angioedema therapy, demonstrating significant efficacy of sebetralstat. FDA approval filing ...
Otsuka's phase 3 trial for AVP-786 in treating agitation in Alzheimer's patients has failed to meet the primary efficacy endpoint. ...
Global medical technology company, Baxter International, has announced a quarterly cash dividend of $0.29 per share. This demonstrates their commitment ...
Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...
Medical technology company TransMedics Group, Inc. is set to release its Q4 and full year 2023 financial results, highlighting its ...
Spectral AI has appointed Dr. J. Michael DiMaio to its Board of Directors as a non-executive member. This move strengthens ...
AN2 Therapeutics' stock rating was downgraded by Oppenheimer after pausing its Phase 3 trial. The company is reassessing and discussing ...
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
Deutsche Bank reiterates Buy rating on Select Medical Holdings Corporation, stating the market is undervaluing the stock & predicting significant ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.